NPM1 and acute myeloid leukemia: The nucleocytoplasmic dysregulation in acute myeloid leukemia (AML) was investigated by Kojima K. at al.; first of all, they demonstrated that elevated XPO1 levels are associated with poor prognosis and they explained the important role of mutated nucleophosmin (NPM1) and p53 in leukemogenesis.